The Comprehensive Guide to Patent Reform Who:                Patent practitioners needing a reminded how the world has changed What:               The critical industry forum on The Leahy-Smith America Invents Act When:              Wednesday, January 23 to Thursday, January 24, 2013 […]

Conference on the Life Cycle of Orphan Drug Development & Commercialization Conducting Effective Orphan Drug Research and Clinical Trials to Expedite Orphan Drug Approval When:    January 16-18, 2013 Where:   Boston, MA Key Topics Improve current rare disease research methods used in early stages of orphan drug development with Genzyme Evaluate where the rare […]

What: “Effective and Practical Strategies for Prosecuting and Litigating Biotech Patents in an Increasingly Uncertain Legal Environment” American Conference Institute’s 14th Advanced Forum on Biotech Patents The ongoing implementation of the America Invents Act and a massive upheaval of subject matter patentability signal that this continues to be a period of intense uncertainty for the biotechnology […]

Join your fellow innovators at the Texas Regional Independent Inventors Conference in Austin as the next stage of the America Invents Acts goes into effect. The United States Patent and Trademark Office (USPTO), National Inventors Hall of Fame and the University of Texas at Austin invite you to get practical advice from successful inventors, entrepreneurs and intellectual property experts. […]

The BIO 2012 convention in Boston, which ran June 18-21 in Boston pulled down a fair number of tweets in the process. Here are some we noticed: Mike Spear ‏@mikesgene @erinatbio #bio2012 payed off for us. BIORadio gave me a chance to speak with researchers and gov’t funders we haven’t tracked down at home. BIOIntl […]

After an exhausting time at BIO 2012, we can finally call it a wrap.  Here’s a sampling of the reporting around the blogosphere on the convention: Julie M. Donnelly at the Boston Business Journal gave the final numbers for BIO 2012: official tally of 16,505 attendees, down from the 22,000 in 2007. Total economic benefit […]

A panel discussion at BIO 2012 pondered the questions as to whether the America Invents Act (AIA) provides a new option replacing patents to secure freedom-to-operate for internally used innovations in biotechnology. Amendments to 35 U.S.C. Section 273 provide for prior user rights, which protect trade secret owners against patent infringement lawsuits. Therefore, if a company […]

A panel of distinguished lecturers provided thoughts and insights on recent major court cases in the biotech arena — and the decision-making behind them. In a discussion on the effects of Prometheus (and Myriad), the consensus seemed to be that there’s no consensus. On Prometheus, the panel tackled the question of how will the decision […]